100 related articles for article (PubMed ID: 20208508)
1. Rebuilding Humpty Dumpty with a serotonin inhibitor.
Seeman E
Nat Med; 2010 Mar; 16(3):264-5. PubMed ID: 20208508
[No Abstract] [Full Text] [Related]
2. Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis.
Yadav VK; Balaji S; Suresh PS; Liu XS; Lu X; Li Z; Guo XE; Mann JJ; Balapure AK; Gershon MD; Medhamurthy R; Vidal M; Karsenty G; Ducy P
Nat Med; 2010 Mar; 16(3):308-12. PubMed ID: 20139991
[TBL] [Abstract][Full Text] [Related]
3. Ursolic acid derivatives as bone anabolic agents targeted to tryptophan hydroxylase 1 (Tph-1).
Fu HJ; Zhao Y; Zhou YR; Bao BH; Du Y; Li JX
Eur J Pharm Sci; 2015 Aug; 76():33-47. PubMed ID: 25930119
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of serotonin inhibition in mouse models of bone loss.
Inose H; Zhou B; Yadav VK; Guo XE; Karsenty G; Ducy P
J Bone Miner Res; 2011 Sep; 26(9):2002-11. PubMed ID: 21608033
[TBL] [Abstract][Full Text] [Related]
5. Regulation of bone mass by serotonin: molecular biology and therapeutic implications.
Karsenty G; Yadav VK
Annu Rev Med; 2011; 62():323-31. PubMed ID: 21073335
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan hydroxylase 1 (Tph-1)-targeted bone anabolic agents for osteoporosis.
Fu HJ; Zhou YR; Bao BH; Jia MX; Zhao Y; Zhang L; Li JX; He HL; Zhou XM
J Med Chem; 2014 Jun; 57(11):4692-709. PubMed ID: 24844139
[TBL] [Abstract][Full Text] [Related]
7. LRP5, serotonin, and bone: complexity, contradictions, and conundrums.
Goltzman D
J Bone Miner Res; 2011 Sep; 26(9):1997-2001. PubMed ID: 21713997
[No Abstract] [Full Text] [Related]
8. Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract.
Liu Q; Yang Q; Sun W; Vogel P; Heydorn W; Yu XQ; Hu Z; Yu W; Jonas B; Pineda R; Calderon-Gay V; Germann M; O'Neill E; Brommage R; Cullinan E; Platt K; Wilson A; Powell D; Sands A; Zambrowicz B; Shi ZC
J Pharmacol Exp Ther; 2008 Apr; 325(1):47-55. PubMed ID: 18192499
[TBL] [Abstract][Full Text] [Related]
9. Short peptides stimulate serotonin expression in cells of brain cortex.
Khavinson VKh; Lin'kova NS; Tarnovskaya SI; Umnov RS; Elashkina EV; Durnova AO
Bull Exp Biol Med; 2014 May; 157(1):77-80. PubMed ID: 24909721
[TBL] [Abstract][Full Text] [Related]
10. [Serotonin: a messenger between the brain/small intestine and the skeleton. Animal models strengthen the hypothesis about the role of serotonin in bone formation].
Lerner UH; Ohlsson C; Ahlman H; Mellström D
Lakartidningen; 2011 Mar 16-22; 108(11):600-5. PubMed ID: 21516677
[No Abstract] [Full Text] [Related]
11. Enteric serotonergic neurones ... finally!
Gershon MD
J Physiol; 2009 Feb; 587(3):507. PubMed ID: 19182271
[No Abstract] [Full Text] [Related]
12. Substituted 3-(4-(1,3,5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitors.
Jin H; Cianchetta G; Devasagayaraj A; Gu K; Marinelli B; Samala L; Scott S; Stouch T; Tunoori A; Wang Y; Zang Y; Zhang C; David Kimball S; Main AJ; Ding ZM; Sun W; Yang Q; Yu XQ; Powell DR; Wilson A; Liu Q; Shi ZC
Bioorg Med Chem Lett; 2009 Sep; 19(17):5229-32. PubMed ID: 19631532
[TBL] [Abstract][Full Text] [Related]
13. Serotonin synthesis by two distinct enzymes in Drosophila melanogaster.
Coleman CM; Neckameyer WS
Arch Insect Biochem Physiol; 2005 May; 59(1):12-31. PubMed ID: 15822093
[TBL] [Abstract][Full Text] [Related]
14. Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension.
Morecroft I; Dempsie Y; Bader M; Walther DJ; Kotnik K; Loughlin L; Nilsen M; MacLean MR
Hypertension; 2007 Jan; 49(1):232-6. PubMed ID: 17130306
[TBL] [Abstract][Full Text] [Related]
15. Editorial overview: serotonergic agents in functional GI disorders: targeting the brain-gut axis.
Wessinger S; Jones MP; Crowell MD
Curr Opin Investig Drugs; 2005 Jul; 6(7):663-6. PubMed ID: 16044660
[No Abstract] [Full Text] [Related]
16. Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex. Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine.
Fletcher PJ; Selhi ZF; Azampanah A; Sills TL
Neuropsychopharmacology; 2001 Apr; 24(4):399-409. PubMed ID: 11182535
[TBL] [Abstract][Full Text] [Related]
17. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.
Li X; Ominsky MS; Warmington KS; Morony S; Gong J; Cao J; Gao Y; Shalhoub V; Tipton B; Haldankar R; Chen Q; Winters A; Boone T; Geng Z; Niu QT; Ke HZ; Kostenuik PJ; Simonet WS; Lacey DL; Paszty C
J Bone Miner Res; 2009 Apr; 24(4):578-88. PubMed ID: 19049336
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of tetrahydropapaverine on serotonin biosynthesis in murine mastocytoma P815 cells.
Kim EI; Kang MH; Lee MK
Life Sci; 2004 Sep; 75(16):1949-57. PubMed ID: 15306162
[TBL] [Abstract][Full Text] [Related]
19. L-tryptophan during gestation induces an increase in brain tryptophan 5-hydroxylase activity and serotonin synthesis.
Chagoya G; Hernández J
Proc West Pharmacol Soc; 1983; 26():369-72. PubMed ID: 6310631
[No Abstract] [Full Text] [Related]
20. Effects of amphetamines on regional tryptophan hydroxylase activity and synaptosomal conversion of tryptophan to 5-hydroxytryptamine in rat brain.
Knapp S; Mandell AJ; Geyer MA
J Pharmacol Exp Ther; 1974 Jun; 189(3):676-89. PubMed ID: 4843167
[No Abstract] [Full Text] [Related]
[Next] [New Search]
